Ozempic and Wegovy make the list of the next 15 drugs in Medicare negotiations: HHS
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer treatment Calquence, GSK’s chronic obstructive pulmonary disorder (COPD) drug Breo Ellipta, and AbbVie’s antipsychotic medication Vraylar.
How Ozempic is being misused and worsening eating disorders - IN FOCUS: Olivia Petter talks to experts who say that people ...
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are ...
Big Pharma is hiding a massive secret about so-called miracle weight-loss drugs like Ozempic – they come with a raft of potentially devastating side effects and can also trap users on an endless merry ...
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...
Current health news highlights include debates over Medicare pricing for drugs like Ozempic and Wegovy, management shifts ...
January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...
The use of GLP-1 drugs sparked the term "Ozempic shaming" to describe the negative perceptions faced by those who choose ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback